Welcome to LookChem.com Sign In|Join Free

CAS

  • or

153877-56-6

Post Buying Request

153877-56-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

153877-56-6 Usage

General Description

1-(3,5-DIFLUOROPHENYL)ETHANOL, also known as difluorophenylethanol, is a chemical compound with the molecular formula C8H7F2O. It is a colorless liquid with a molecular weight of 154.14 g/mol. 1-(3,5-DIFLUOROPHENYL)ETHANOL is often used in pharmaceutical research and can act as a building block in the synthesis of various drugs and other organic compounds. It is also used as a solvent in chemical reactions and as a reagent in organic synthesis. Difluorophenylethanol has potential applications in the development of new medications and chemical processes due to its unique chemical properties. However, it is important to handle this compound with care and adhere to safety guidelines when working with it in a laboratory setting.

Check Digit Verification of cas no

The CAS Registry Mumber 153877-56-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,8,7 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 153877-56:
(8*1)+(7*5)+(6*3)+(5*8)+(4*7)+(3*7)+(2*5)+(1*6)=166
166 % 10 = 6
So 153877-56-6 is a valid CAS Registry Number.

153877-56-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H31848)  3,5-Difluorobenzhydrol, 95%   

  • 153877-56-6

  • 1g

  • 509.0CNY

  • Detail
  • Alfa Aesar

  • (H31848)  3,5-Difluorobenzhydrol, 95%   

  • 153877-56-6

  • 5g

  • 1704.0CNY

  • Detail

153877-56-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,5-Difluorobenzhydrol

1.2 Other means of identification

Product number -
Other names 1-(3,5-DIFLUOROPHENYL)ETHANOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:153877-56-6 SDS

153877-56-6Relevant articles and documents

Direct C–H Carboxylation Forming Polyfunctionalized Aromatic Carboxylic Acids by Combined Br?nsted Bases

Hanasaka, Kazuya,Izumi, Koki,Kondo, Yoshinori,Kwon, Eunsang,Nozawa-Kumada, Kanako,Shigeno, Masanori,Tohara, Itsuki,Yamakoshi, Hiroyuki

supporting information, p. 809 - 814 (2022/02/05)

CO2 fixation into electron-deficient aromatic C–H bonds proceeds with the combined Br?nsted bases LiO-t-Bu and LiO-t-Am/CsF/18-crown-6 (t-Am = CEtMe2) under a CO2 atmosphere to afford a variety of polyfunctionalized aromat

Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase

Winters, Maria,DuHadaway, James B.,Pham, Khoa N.,Lewis-Ballester, Ariel,Badir, Shorouk,Wai, Jenny,Sheikh, Eesha,Yeh, Syun-Ru,Prendergast, George C.,Muller, Alexander J.,Malachowski, William P.

supporting information, p. 455 - 464 (2018/11/25)

Tryptophan (Trp) catabolizing enzymes play an important and complex role in the development of cancer. Significant evidence implicates them in a range of inflammatory and immunosuppressive activities. Whereas inhibitors of indoleamine 2,3-dioxygenase-1 (IDO1) have been reported and analyzed in the clinic, fewer inhibitors have been described for tryptophan dioxygenase (TDO) and indoleamine 2,3-dioxygenase-2 (IDO2) which also have been implicated more recently in cancer, inflammation and immune control. Consequently the development of dual or pan inhibitors of these Trp catabolizing enzymes may represent a therapeutically important area of research. This is the first report to describe the development of dual and pan inhibitors of IDO1, TDO and IDO2.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 153877-56-6